Immatics at ASGCT’s pre-meeting CAR T and Immune Effector Cell Therapies Workshop (May 11)
Join us on May 11 for the CAR T and Immune Effector Cell Therapies Workshop to take place virtually right before the American Society of Gene and Cell Therapy 23rd Annual Meeting!
E-meet Amir Alpert then and there and learn more about our TCR-based cancer immunotherapies.
Monday, May 11, 9.40am – 10am EST (2.40pm GMT / 3.40pm CET)
TCR-Based Cancer Immunotherapies to Novel pMHC Targets
- Introduction to Immatics‘ target discovery engine XPRESIDENT® and next-generation technology platform XCEPTORTM
- Overview of how thus characterized and optimized TCR candidates are developed towards adoptive cell therapy applications such as Immatics’ phase 1/2 ACTengine® trials
Speaker: Amir Alpert, Assoc. Director Immunology
We are looking forward to virtually meeting you!
Learn more about the ASGCT and it’s CAR T and Immune Effector Cell Therapies Workshop here.